Linda Hayes Bennett on The Terrain-Level Determinants of Ischemic Stroke
Linda Hayes Bennett, Cognitive-Behavioral Neuroscientist, shared on LinkedIn:
”Abstract: The Terrain-Level Determinants of Ischemic Stroke — An ALH–eGFR Framework for Precision Prevention
While ischemic stroke is classically categorized by mechanism—embolism, thrombosis, dissection, or small-vessel disease—these visible outcomes emerge from deeper, measurable changes in the body’s terrain.
In this integrated framework, stroke risk is redefined not as an isolated vascular event but as the endpoint of cumulative terrain erosion.
Declining eGFR (estimated glomerular filtration rate), endothelial microinjury, oxidative stress, dehydration, and allostatic overload together alter plasma viscosity, shear dynamics, and mitochondrial resilience—conditions that silently prepare the vasculature for failure.
Likewise, caregiving stress, malnutrition, and iatrogenic medication patterns accelerate inflammatory cascades and vascular fragility.
The ALH Caregiver Index, paired with eGFR trajectories, identifies early inflection points where preventive interventions—hydration, oxygenation, rhythm regulation, cooling therapy, and caregiver education—can preserve neuronal integrity and reduce stroke incidence.
This terrain-based model reframes prevention around upstream metrics of biological and behavioral health, bridging patient care, public health, and precision medicine.”
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Oct 20, 2025, 12:46Linda Hayes Bennett on The Terrain-Level Determinants of Ischemic Stroke
-
Oct 19, 2025, 12:13Mohammed AlSheef Invites You to First Saudi PERT Symposium
-
Oct 19, 2025, 11:39Understanding Blood Cells: The Vital Components of Life
-
Oct 19, 2025, 11:18Simon Mayr: An Inspiring Interview with Dr. Carmelo Gurnari
-
Oct 19, 2025, 06:11Soumya Sayujya: A Routine Lab, An Incidental Finding, And a Lesson I Won’t Forget
-
Oct 20, 2025, 12:33Emmanuel J Favaloro Shares Summary Table To Understand The Complexity of von Willebrand Factor
-
Oct 20, 2025, 12:17Alexander Hermann and Colleagues On Post-ECMO Thrombosis
-
Oct 20, 2025, 12:02Fabrice Cognasse on The Inflammatory Role of Platelets in Blood Transfusion
-
Oct 20, 2025, 05:31Sebastian Szmit: Important Review Published Today By My Research Group
-
Oct 20, 2025, 05:18Hossam El Benawi: Loading Dose While Treating LVT Could Mitigate Stroke
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 20, 2025, 12:40Asfand Yar Cheema: Honored to be featured in Video Journal of Hematology and Hematological Oncology
-
Oct 20, 2025, 12:25Laurent Bertoletti Highlights Evolving Role of Anticoagulation in Pulmonary Hypertension Treatment
-
Oct 20, 2025, 05:02Crystal P: AI Is Not Replacing Human Expertise, It’s Expanding It
-
Oct 20, 2025, 03:48David Calvet Canut on Europe's Plasma Dependency
-
Oct 19, 2025, 11:41Dr Arun V J: From “Average Student” to Leader in Transfusion Medicine